Cite

HARVARD Citation

    Greenland, N. et al. (2020). Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category. Prostate. 80 (16), pp. 1421-1428. [Online]. 
  
Back to record